Northstar Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $2.41M | Hold |
35,473
| – | – | 0.32% | 74 |
|
|
2021
Q1 | $2.24M | Sell |
35,473
-2,050
| -5% | -$128K | 0.33% | 78 |
|
|
2020
Q4 | $2.33M | Sell |
37,523
-75
| -0.2% | -$4.61K | 0.36% | 68 |
|
|
2020
Q3 | $2.27M | Sell |
37,598
-10,060
| -21% | -$605K | 0.41% | 66 |
|
|
2020
Q2 | $2.8M | Hold |
47,658
| – | – | 0.59% | 53 |
|
|
2020
Q1 | $2.66M | Sell |
47,658
-4,755
| -9% | -$291K | 0.66% | 55 |
|
|
2019
Q4 | $3.36M | Sell |
52,413
-1,425
| -3% | -$81.6K | 0.53% | 65 |
|
|
2019
Q3 | $2.59M | Buy |
53,838
+16,953
| +46% | +$797K | 0.43% | 67 |
|
|
2019
Q2 | $1.67M | Sell |
36,885
-1,545
| -4% | -$72K | 0.31% | 64 |
|
|
2019
Q1 | $1.83M | Sell |
38,430
-3,780
| -9% | -$188K | 0.34% | 63 |
|
|
2018
Q4 | $2.19M | Sell |
42,210
-900
| -2% | -$48.4K | 0.48% | 50 |
|
|
2018
Q3 | $2.68M | Sell |
43,110
-395
| -0.9% | -$23.4K | 0.53% | 46 |
|
|
2018
Q2 | $2.41M | Sell |
43,505
-2,310
| -5% | -$125K | 0.5% | 48 |
|
|
2018
Q1 | $2.9M | Sell |
45,815
-5,406
| -11% | -$348K | 0.61% | 48 |
|
|
2017
Q4 | $3.14M | Sell |
51,221
-580
| -1% | -$36.3K | 0.57% | 53 |
|
|
2017
Q3 | $3.3M | Sell |
51,801
-596
| -1% | -$34.8K | 0.64% | 51 |
|
|
2017
Q2 | $2.92M | Buy |
52,397
+826
| +2% | +$44.9K | 0.59% | 50 |
|
|
2017
Q1 | $2.8M | Sell |
51,571
-116,628
| -69% | -$6.4M | 0.57% | 52 |
|
|
2016
Q4 | $9.83M | Buy |
168,199
+5,377
| +3% | +$294K | 2.2% | 12 |
|
|
2016
Q3 | $8.03M | Buy |
162,822
+3,468
| +2% | +$223K | 1.84% | 21 |
|
|
2016
Q2 | $11.7M | Buy |
159,354
+1,740
| +1% | +$123K | 2.7% | 4 |
|
|
2016
Q1 | $10.1M | Buy |
157,614
+2,271
| +1% | +$143K | 2.45% | 8 |
|
|
2015
Q4 | $10.7M | Buy |
155,343
+383
| +0.2% | +$25.3K | 2.76% | 4 |
|
|
2015
Q3 | $9.17M | Buy |
154,960
+919
| +0.6% | +$58.3K | 2.51% | 7 |
|
|
2015
Q2 | $10.3M | Sell |
154,041
-3,376
| -2% | -$222K | 2.65% | 3 |
|
|
2015
Q1 | $10.2M | Sell |
157,417
-2,108
| -1% | -$132K | 2.59% | 3 |
|
|
2014
Q4 | $9.42M | Buy |
159,525
+337
| +0.2% | +$19K | 2.36% | 3 |
|
|
2014
Q3 | $8.15M | Buy |
159,188
+341
| +0.2% | +$17K | 2.12% | 6 |
|
|
2014
Q2 | $7.71M | Sell |
158,847
-4,209
| -3% | -$207K | 1.99% | 7 |
|
|
2014
Q1 | $8.47M | Buy |
163,056
+1,164
| +0.7% | +$61.9K | 2.25% | 4 |
|
|
2013
Q4 | $8.61M | Buy |
161,892
+2,792
| +2% | +$142K | 2.36% | 4 |
|
|
2013
Q3 | $7.36M | Buy |
159,100
+2,076
| +1% | +$91.1K | 2.21% | 4 |
|
|
2013
Q2 | $7.02M | Buy |
+157,024
| New | +$6.82M | 2.2% | 5 |
|
Other funds holding BMY
Northstar Investment Advisors's BMY Position: Q2 2021 in Review
Northstar Investment Advisors held its Bristol-Myers Squibb (BMY) position steady in Q2 2021 at 35,473 shares worth $2.41M. The position accounts for 0.32% of the portfolio, ranked #74.
Northstar Investment Advisors first reported a position in BMY in Q2 2013 and has held it in 33 quarters since. The position peaked at $11.7M in Q2 2016. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.
- Northstar Investment Advisors held 35,473 shares of Bristol-Myers Squibb worth $2.41M as of Q2 2021.
- Northstar Investment Advisors left its Bristol-Myers Squibb share count unchanged in Q2 2021.
- Bristol-Myers Squibb made up 0.32% of Northstar Investment Advisors's portfolio in Q2 2021, its #74 holding.
- Northstar Investment Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 33 quarters since.
- Northstar Investment Advisors's Bristol-Myers Squibb position peaked at $11.7M in Q2 2016.
- 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.
Based on Northstar Investment Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.